PGL2001 Proof of Concept Study in Symptomatic Endometriosis
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
This is a Phase II, multicentre, randomised, two-arm, parallel group ,double-blind, placebo
controlled, study to investigate the efficacy, safety, pharmacokinetics and pharmacodynamics
of the steroid sulfatase inhibitor PGL2001 with concomitant, continuous NETA administration
for the treatment of pain symptoms suggestive of endometriosis. The target population will be
women of reproductive age with symptoms suggestive of endometriosis.